Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
28.10.2022 17:25:00

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR

NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Equillium, Inc. (NASDAQ: EQ)'s merger with Metacrine Inc. If you are an Equillium shareholder, click here to learn more about your rights and options.  

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT)'s merger with Renovacor, Inc. If you are a Rocket shareholder, click here to learn more about your rights and options.

Ra Medical Systems, Inc. (NYSE: RMED)'s merger with Catheter Precision, Inc. If you are a Ra Medical shareholder, click here to learn more about your rights and options.  

Renovacor, Inc. (NYSE: RCOR)'s sale to Rocket Pharmaceuticals, Inc. for approximately 0.1676 shares of Rocket for each Renovacor share. Upon completion of the transaction, Renovacor shareholders are expected to own approximately 4.6% percent of Rocket. If you are a Renovacor Health shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-eq-rckt-rmed-rcor-301662373.html

SOURCE Halper Sadeh LLP

Nachrichten zu Equillium Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Equillium Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Equillium Inc Registered Shs 0,71 -2,08% Equillium Inc Registered Shs
Rocket Pharmaceuticals 13,07 -2,10% Rocket Pharmaceuticals